methylprednisolone has been researched along with candesartan in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Iijima, K; Kamei, K; Kobayashi, S; Matsuoka, K; Nakagawa, A; Nakayama, M; Otsuka, Y | 1 |
Bairey Merz, CN; Berman, DS; Goykhman, P; Ishimori, ML; Mehta, PK; Minissian, M; Shufelt, CL; Thomson, LE; Wallace, DJ; Weisman, MH | 1 |
1 review(s) available for methylprednisolone and candesartan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for methylprednisolone and candesartan
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Chronic glomerulonephritis associated with IgG subclass deficiency.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Benzimidazoles; Biopsy; Biphenyl Compounds; Case-Control Studies; Chronic Disease; Female; Fluorescent Antibody Technique; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Humans; IgG Deficiency; Immunoglobulin Isotypes; Immunoglobulin M; Immunoglobulins, Intravenous; Kidney Glomerulus; Male; Methylprednisolone; Periodic Acid-Schiff Reaction; Pulse Therapy, Drug; Tetrazoles; Time Factors; Treatment Outcome | 2007 |
Subendocardial ischemia and myocarditis in systemic lupus erythematosus detected by cardiac magnetic resonance imaging.
Topics: Anti-Inflammatory Agents; Benzimidazoles; Biphenyl Compounds; Chest Pain; Coronary Angiography; Coronary Vessels; Endocardium; Female; Humans; Hydroxychloroquine; Ischemia; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Myocarditis; Tetrazoles; Treatment Outcome | 2012 |